Mosaic opened lower at $18.06, compared with its previous close of $18.23. In the last trading session, the stock traded between $18.04 and $18.46. It showed a sideways intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Mosaic is now worth
$ 44.03
resulting in a loss of
$ 55.97 (55.97%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 12 Analysts
Buy
33.33%
Hold
66.67%
Sell
0%
Markets Today
Today's Change
+$0.08 (+0.41%)
Day High
$18.46
Day Low
$18.04
Day Open
$18.06
Prev Close
$18.23
Volume
27,84,210
1W Return
6.10%
1M Return
-18.32%
3M Return
-19.05%
6M Return
-20.52%
1Y Return
-36.11%
Fundamentals
Market Cap ($ Mn)
5,819
PE Ratio
-
PB Ratio
0.65
PEG Ratio
-
ROE
4.75%
ROCE
7.11%
EPS (TTM)
$-0.86
Investment Returns
1 Week
6.10%
1 Month
-18.32%
3 Months
-19.05%
6 Months
-20.52%
9 Months
-34.72%
Financials
Quarterly
All values in $ Mn
0.0
Sep 25
3.5K
Sep 25
3.0K
Dec 25
0.0
Mar 26
3.0K
Mar 26
2.8K
Jun 26
Updates
17Oct
Barclays lowers Mosaic price target to $22, keeps equal-weight rating
Barclays lowered Mosaic's price target from $26 to $22. Analyst Benjamin Theurer maintained an Equal-Weight rating. The price target reduction reflects updated valuation assumptions.
13 days ago
17Aug
Mosaic Biosciences launches Renuvis Enzara to accelerate crop residue breakdown
Mosaic Biosciences has launched Renuvis Enzara, a biological solution using endoglucanase enzyme technology to accelerate crop residue decomposition. The product addresses challenges from heavy residue in no-till and high-yield systems, aiming to widen planting windows and improve machinery performance. Backed by 2025 on-farm trials showing improved emergence and stand counts, it offers a tank-mix compatible application for fall or spring use.
2mo ago
17Aug
Mosaic completes $1.4 billion debt tender offer for four note series
Mosaic finalized its $1.4 billion debt tender offer, accepting all tendered 2027 and 2028 notes/debentures and a prorated 37.78% of 2029 notes after increasing the series cap. Settlement is scheduled for August 18, 2026.
2mo ago
6Aug
Mosaic warns global phosphate output to fall short by 30 million tons
Mosaic forecasts a 30 million ton deficit in global phosphate production due to high sulfur prices caused by the Strait of Hormuz closure and Kazakhstan blockade. Tight supplies are further exacerbated by reduced Chinese exports, though potash markets remain stable.
2mo ago
16Jul
Mosaic sets Q2FY26 earnings release for August 4
The Mosaic Company will release its second quarter 2026 earnings results on Tuesday, August 4, following the close of trading. A conference call to discuss the results is scheduled for Wednesday, August 5, at 11:00 a.m. Eastern Time.
3mo ago
30Jun
Morgan Stanley maintains Equal-Weight on Mosaic, cuts target to $26
Morgan Stanley analyst Nigel Dally maintained an Equal-Weight rating on Mosaic (NYSE: MOS) and lowered the price target from $28 to $26, signaling a revised valuation outlook.
